1st stem cell-based drug from local biotechnology company OK’d

A local biotechnology company has gained the world’s first regulatory approval for a stem cell-based drug. Columbia-based Osiris Therapeutics Inc. received approval last week in Canada for the use of its Prochymal drug to treat children with the potentially deadly graft-vs-host disease, or GvHD, a complication of bone marrow transplants. “We essentially have broken through the glass ...

Leave a Reply

Your email address will not be published. Required fields are marked *